English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/181513
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Current status and future perspectives of gold nanoparticle vectors for siRNA delivery

AuthorsArtiga, Álvaro; Serrano-Sevilla, Inés; Matteis, Laura de; Mitchell, Scott G.; Fuente, Jesús M. de la
Issue Date2019
PublisherRoyal Society of Chemistry (UK)
CitationJournal of Materials Chemistry B 7(6): 876-896
AbstractDiscovering the vast therapeutic potential of siRNA opened up new clinical research areas focussing on a number of diseases and applications; however significant problems with siRNA stability and delivery have hindered its clinical applicability. As a result, interest in the development of practical siRNA delivery systems has grown in recent years. Of the numerous siRNA delivery strategies currently on offer, gold nanoparticles (AuNPs) stand out thanks to their biocompatibility and capacity to protect siRNA against degradation; not to mention the versatility offered by their tuneable shape, size and optical properties. Herein this review provides a complete summary of the methodologies for functionalizing AuNPs with siRNA, paying singular attention to the AuNP shape, size and surface coating, since these key factors heavily influence cellular interaction, internalization and, ultimately, the efficacy of the hybrid particle. The most noteworthy hybridization strategies have been highlighted along with the most innovative and outstanding in vivo studies with a view to increasing clinical interest in the use of AuNPs as siRNA nanocarriers.
Publisher version (URL)https://doi.org/10.1039/C8TB02484G
Appears in Collections:(ICMA) Artículos
Files in This Item:
File Description SizeFormat 
A6-current.pdf1,81 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.